High concentrations of glucose suppress etoposide-induced cell death of B-cell lymphoma through BCL-6

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 227-233

  Shao, Yan ^a,b   Ling, Chang Chun ^b,c   Liu, Xu Qing ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c NANTONG UNIVERSITY   (China)

Author keywords

B cell lymphoma; BCL 6; Chemotherapy; Etoposide; Glucose

Indexed keywords

ETOPOSIDE; GLUCOSE; PROTEIN BCL 6; PROTEIN P53; THIOREDOXIN INTERACTING PROTEIN;

ARTICLE; B CELL LYMPHOMA; B-CELL LYMPHOMA CELL LINE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DEATH; CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION;

B-CELL LYMPHOMA; BCL-6; CHEMOTHERAPY; ETOPOSIDE; GLUCOSE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARRIER PROTEINS; CASPASES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ETOPOSIDE; GLUCOSE; HUMANS; LYMPHOMA, B-CELL;

EID: 84904736866     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.05.096     Document Type: Article

References (21)

1. X. Wu, H. Pertovaara, P. Korkola, M. Vornanen, H. Eskola, and P.L. Kellokumpu-Lehtinen Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma Leuk. Lymphoma 53 2012 400 405
2. L. Zeng, K.M. Biernacka, J.M. Holly, C. Jarrett, A.A. Morrison, A. Morgan, Z.E. Winters, E.J. Foulstone, J.P. Shield, and C.M. Perks Hyperglycemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase Endocr. Relat. Cancer 17 2010 539 551
3. T. Tarumi, K. Sawada, K. Koizumi, H. Takano, Y. Fukada, M. Nishio, T. Fujie, K. Ohnishi, M. Kohno, N. Sato, S. Sekiguchi, and T. Koike A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma Leuk. Lymphoma 34 1999 361 371
4. R. Liang, W.P. Chan, Y.L. Kwong, W.S. Xu, G. Srivastava, and F.C. Ho High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin Cancer Genet. Cytogenet. 97 1997 114 118
5. M. Igoillo-Esteve, E.N. Gurzov, D.L. Eizirik, and M. Cnop The transcription factor B-cell lymphoma (BCL)-6 modulates pancreatic {beta}-cell inflammatory responses Endocrinology 152 2011 447 456
6. T. Kurosu, T. Fukuda, T. Miki, and O. Miura BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells Oncogene 22 2003 4459 4468
7. O. Margalit, H. Amram, N. Amariglio, A.J. Simon, S. Shaklai, G. Granot, N. Minsky, A. Shimoni, A. Harmelin, D. Givol, M. Shohat, M. Oren, and G. Rechavi BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma Blood 107 2006 1599 1607
8. Y. Shao, S.Y. Kim, D. Shin, M.S. Kim, H.W. Suh, Z.H. Piao, M. Jeong, S.H. Lee, S.R. Yoon, B.H. Lim, W.H. Kim, J.K. Ahn, and I. Choi TXNIP regulates germinal center generation by suppressing BCL-6 expression Immunol. Lett. 129 2010 78 84
9. E. Junn, S.H. Han, J.Y. Im, Y. Yang, E.W. Cho, H.D. Um, D.K. Kim, K.W. Lee, P.L. Han, S.G. Rhee, and I. Choi Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function J. Immunol. 164 2000 6287 6295
10. A. Nishiyama, M. Matsui, S. Iwata, K. Hirota, H. Masutani, H. Nakamura, Y. Takagi, H. Sono, Y. Gon, and J. Yodoi Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression J. Biol. Chem. 274 1999 21645 21650
11. A. Nishiyama, H. Masutani, H. Nakamura, Y. Nishinaka, and J. Yodoi Redox regulation by thioredoxin and thioredoxin-binding proteins IUBMB Life 52 2001 29 33
12. H. Yamanaka, F. Maehira, M. Oshiro, T. Asato, Y. Yanagawa, H. Takei, and Y. Nakashima A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system Biochem. Biophys. Res. Commun. 271 2000 796 800
13. T. Yoshida, H. Nakamura, H. Masutani, and J. Yodoi The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process Ann. N. Y. Acad. Sci. 1055 2005 1 12
14. S.H. Han, J.H. Jeon, H.R. Ju, U. Jung, K.Y. Kim, H.S. Yoo, Y.H. Lee, K.S. Song, H.M. Hwang, Y.S. Na, Y. Yang, K.N. Lee, and I. Choi VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression Oncogene 22 2003 4035 4046
15. M. Carmagnat, B. Drenou, H. Chahal, J.M. Lord, D. Charron, J. Estaquier, and N.A. Mooney Dissociation of caspase-mediated events and programmed cell death induced via HLA-DR in follicular lymphoma Oncogene 25 2006 1914 1921
16. M.G. Vander Heiden, D.R. Plas, J.C. Rathmell, C.J. Fox, M.H. Harris, and C.B. Thompson Growth factors can influence cell growth and survival through effects on glucose metabolism Mol. Cell. Biol. 21 2001 5899 5912
17. H.J. Huber, H. Dussmann, S.M. Kilbride, M. Rehm, and J.H. Prehn Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release Mol. Syst. Biol. 7 2011 470
18. G. Studer, B. Seifert, and C. Glanzmann Prediction of distant metastasis in head neck cancer patients: implications for induction chemotherapy and pre-treatment staging? Strahlenther. Onkol. 184 2008 580 585
19. R.T. Phan, and R. Dalla-Favera The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells Nature 432 2004 635 639
20. M. Schuler, E. Bossy-Wetzel, J.C. Goldstein, P. Fitzgerald, and D.R. Green P53 induces apoptosis by caspase activation through mitochondrial cytochrome c release J. Biol. Chem. 275 2000 7337 7342
21. Q. Liu, S. Hilsenbeck, and Y. Gazitt Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL Blood 101 2003 4078 4087